Udo Ehrenfeld

The topic of this article may not meet Wikitia's general notability guideline. Please help to demonstrate the notability of the topic by citing reliable secondary sources that are independent of the topic and provide significant coverage of it beyond a mere trivial mention. If notability cannot be shown, the article is likely to be merged, redirected, or deleted. Find sources: "Udo Ehrenfeld" – news · newspapers · books · scholar · JSTOR (Learn how and when to remove this template message)

Kurt-Udo Ehrenfeld (born June 4, 1942) was a German immunologist who created a novel cancer imagine technique and therapeutic that was derived from a cell wall extract of the bacteria Nocardia opaca.

Biography[edit]

He was born in Tübingen, Germany in 1942. He died in Recife, Brazil 13 April 2001. He founded Jomol Pharma GmbH in Regensburg, Germany on the 29th July 1985.^[1]

He had worked at the renowned Max Planck institute around 1974 and developed the "German Ehrenfeld" program as it was called at the time.^[2]

A book entitled written "Ich lebe noch!" in 1996 telling the story of individuals who had improved with his novel cancer therapeutic agent.

References[edit]

External links[edit]

Add External links

This article "Udo Ehrenfeld" is from Wikipedia. The list of its authors can be seen in its historical. Articles taken from Draft Namespace on Wikipedia could be accessed on Wikipedia's Draft Namespace.